ArticleTranslational lung cancer research2024

CDK4/6 inhibitor abemaciclib combined with low-dose radiotherapy enhances the anti-tumor immune response to PD-1 blockade by inflaming the tumor microenvironment in Rb-deficient small cell lung cancer.

Laduona Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.